首页> Frontiers in oncology> Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer.

Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Alexander,Schulz

第一单位： Faculty of Medicine and University Hospital Carl Gustav Carus, OncoRay-National Center for Radiation Research in Oncology, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.

作者： Alexander,Schulz ^[1] ; Ielizaveta,Gorodetska ^[1] ; Rayk,Behrendt ^[2] ; Susanne,Fuessel ^[3] ; Kati,Erdmann ^[3] ; Sarah,Foerster ^[4] ; Kaustubh,Datta ^[5] ; Thomas,Mayr ^[4] ; Anna,Dubrovska ^[6] ; Michael H,Muders ^[4]

作者单位： Faculty of Medicine and University Hospital Carl Gustav Carus, OncoRay-National Center for Radiation Research in Oncology, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany. ^[1] Faculty of Medicine, Institute for Immunology, Technische Universität Dresden, Dresden, Germany. ^[2] Department of Urology, Technische Universität Dresden, Dresden, Germany. ^[3] Rudolf Becker Laboratory for Prostate Cancer Research, Center of Pathology, University of Bonn Medical Center, Bonn, Germany. ^[4] Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, United States. ^[5] Faculty of Medicine and University Hospital Carl Gustav Carus, OncoRay-National Center for Radiation Research in Oncology, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.;Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany.;German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.;German Cancer Research Center (DKFZ), Heidelberg, Germany. ^[6]

关键词 J82 Neuropilin-2 (NRP2)RT112 bladder cancer epithelial-to-mesenchymal transition (EMT)glioma-associated oncogene family zinc finger 2 (GLI2)osteopontin (OPN)secreted phosphoprotein 1 (SPP1)

DOI 10.3389/fonc.2019.01461

PMID 32038994

发布时间 2024-04-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交